Solvo Biotechnology

Budaors, Hungary Founded: 1999 • Age: 27 yrs Acquired By CiToxLAB
Develops transporter assays

About Solvo Biotechnology

Solvo Biotechnology is a Healthcare company based in Budaors (Hungary) founded in 1999, and was acquired by CiToxLAB in March 2018. It develops transporter assays. Solvo Biotechnology offers products and services including Transporter Kits, Uptake Transporter Services, Efflux Transporter Services, and Metabolism Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays.

Company details

Solvo Biotechnology was founded in 1999 in Budaors, Hungary, within the biotechnology sector. Transporter assays are developed and commercialized, including reagent kits for in vitro applications such as dye efflux, hepatocyte uptake, multidrug resistance, uptake transporter, and vesicular transport assays. In vivo imaging solutions compatible with PET and other modalities are also provided to support research operations.

Key Metrics

Products & Services of Solvo Biotechnology

Solvo Biotechnology offers a comprehensive portfolio of products and services, including Transporter Kits, Uptake Transporter Services, Efflux Transporter Services, and Metabolism Services.

Transporter Kits
Products

Kits for uptake and efflux transporter assays

Uptake Transporter Services
Services

Assays for drug transporter studies in cells

Efflux Transporter Services
Services

Services for efflux transporter evaluations

Metabolism Services
Services

Tests for CYP450 and UGT inhibition processes

Investors in Solvo Biotechnology

Solvo Biotechnology has secured backing from 1 investor. Prominent investors backing the company include CiToxLAB.

All
InvestorDescriptionFounded YearDomainLocation
In vivo and in vitro toxicology services are provided globally.
1969citoxlab.comEvreux, France
Premium access

Investor details for Solvo Biotechnology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Solvo Biotechnology

2 dated milestones of Solvo Biotechnology across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Solvo Biotechnology is founded.
  2. Exit Acquired by CiToxLAB.

Web traffic of Solvo Biotechnology

The website of Solvo Biotechnology (solvobiotech.com) receives about 7.7K visits a month and ranks #2,587,691 among all websites worldwide, #3,548 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    7.7K

    ▼ 3.7% vs previous month

  • Unique visitors
    3.3K

    per month

  • Global rank
    #2,587,691

    among all websites

  • Category rank
    #3,548

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Solvo Biotechnology. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hungarianbiotech.org
hungarianbiotech.org
100%
#10,139,291–
astrazeneca.hu
astrazeneca.hu
82%
–
egis.hu
egis.hu
82%
#1,831,795–
fdbhealth.com
56%
#1,633,474View details
facebook.com
29%
12.1B#3View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Solvo Biotechnology

Solvo Biotechnology was founded in 1999.

Solvo Biotechnology is headquartered in Budaors, Hungary. It is registered at Budaors, Pest County, Hungary.

Solvo Biotechnology was founded in 1999 in Budaors, Hungary, within the biotechnology sector. Transporter assays are developed and commercialized, including reagent kits for in vitro applications such as dye efflux, hepatocyte uptake, multidrug resistance, uptake transporter, and vesicular transport assays. In vivo imaging solutions compatible with PET and other modalities are also provided to support research operations.

Solvo Biotechnology offers Transporter Kits, Uptake Transporter Services, Efflux Transporter Services, and Metabolism Services.

Solvo Biotechnology has 1 investor. Key investors include CiToxLAB.

Yes. Solvo Biotechnology was acquired by CiToxLAB in March 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available